Job titles of the future: Nature’s drug designer

2026-06-11 · Source: MIT Technology Review · Field: Science & Research — Life Sciences & Biology, Environmental Science & Earth Systems, Artificial Intelligence & Machine Learning · Depth: Intermediate, quick

Summary

Chemist Tim Cernak, formerly of Merck, is pioneering "conservation chemistry," a new discipline applying precision drug design to treat diseases in ecosystems. Starting in 2018, Cernak transitioned from developing human therapies for cancer, HIV, and diabetes to addressing ailments in animals and plants, noting that current veterinary pharmaceuticals are often indiscriminate and harmful, like itraconazole for frogs. Now an associate professor at the University of Michigan, his work involves treating diverse patients, from Gila monsters with parasites to bald eagles with avian flu and hemlock trees with invasive species. He utilizes Google DeepMind's AlphaFold for visualizing protein structures and robots to rapidly screen up to 1,500 potential drugs daily, significantly accelerating the design workflow. Cernak acknowledges the historical risks of chemicals in conservation, such as DDT's impact on bald eagles, but argues for chemists' inclusion to develop advanced, targeted solutions for environmental health.

Key takeaway

For research scientists and conservationists seeking advanced solutions for ecological health, consider integrating precision chemistry and AI-driven drug design. Your current reliance on broad-spectrum treatments for non-human patients may cause unintended harm. Explore applying protein-modeling software and high-throughput screening to develop targeted therapies for specific species or environmental threats, moving beyond outdated chemical tools to address mass extinction challenges effectively.

Key insights

Precision drug design, enhanced by AI, can be applied to conservation for targeted ecological health solutions.

Principles

• Existing human drugs harm non-human patients.
• AI accelerates drug design workflows.
• Conservation needs advanced chemical tools.

Method

Utilize protein-modeling software like AlphaFold to visualize 3D protein structures, then rapidly generate and screen potential drugs using robotic lab automation.

In practice

• Treat amphibians with targeted antifungals.
• Develop precision insecticides for trees.
• Design therapies for endangered species.

Topics

• Conservation Chemistry
• Precision Drug Design
• AlphaFold
• Ecological Health
• AI in Drug Discovery
• Wildlife Medicine

Best for: AI Scientist, Research Scientist, Domain Expert

Related on AIssential

• The Future Of Drug Discovery Is 4 Billion Years Old (Viswa Colluru, Founder & CEO at Enveda) — AI-driven exploration of nature's chemistry offers a potent, overlooked pathway for discovering first-in-class, affordable medicines.
• AI can design viruses, toxins and other bioweapons. How worried should we be? — AI tools in biology present a dual-use dilemma, offering drug discovery benefits while raising bioweapon design and proliferation risks.
• Two AI-based science assistants succeed with drug-retargeting tasks — AI-powered agentic systems can accelerate scientific discovery by synthesizing vast literature and generating testable hypotheses.
• Why We're Not Close to AI Drugs Yet | Isomorphic Labs — Drug design comprises multiple distinct ML problems, not a single one, despite AlphaFold 2's protein structure prediction success.
• Demis Hassabis On What AI Will Do Next — AI is evolving into a co-creative partner, poised to accelerate scientific discovery and revolutionize human health within decades.
• The scientist using AI to hunt for antibiotics just about everywhere — AI-driven peptide discovery from diverse biological sources offers a novel approach to combat antimicrobial resistance.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by MIT Technology Review.